BioMarin Pharmaceutical Inc.: BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
finanznachrichten.de
BioMarin Pharmaceutical Inc.: BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and
BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with
4 months ago
BioMarin Pharmaceutical Products
BioMarin Pharmaceutical erhält EU-Zulassung für die Übernahme von Amicus Therapeutics
BioMarin Pharmaceutical erhält EU-Zulassung für die Übernahme von Amicus Therapeutics
marketscreener.com
1 week ago
BioMarin Pharmaceutical recule en Bourse après une dégradation de Stifel
BioMarin Pharmaceutical recule en Bourse après une dégradation de Stifel
zonebourse.com
5 months ago
Pharmaceutical Commerce | LinkedIn
Pharmaceutical Commerce | LinkedIn
linkedin.com
Apr 11, 2011
Top videos
At BioMarin, we're driven to develop innovative medicines that transform the lives of those with rare genetic conditions. Learn more about our commitment to clinical research and our active trials. | BioMarin Pharmaceutical Inc.
0:12
At BioMarin, we're driven to develop innovative medicines that transform the lives of those with rare genetic conditions. Learn more about our commitment to clinical research and our active trials. | BioMarin Pharmaceutical Inc.
FacebookBioMarin Pharmaceutical Inc.
261.2K views2 months ago
BioMarin Pharmaceutical Inc.: BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 ...
BioMarin Pharmaceutical Inc.: BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 ...
finanznachrichten.de
9 months ago
Biomarin Pharmaceutical Inc. Announces Positive Results of Phase 2 Proof-Of-Concept and Dose Finding Study of BMN 111
Biomarin Pharmaceutical Inc. Announces Positive Results of Phase 2 Proof-Of-Concept and Dose Finding Study of BMN 111
marketscreener.com
Jun 17, 2015
BioMarin Pharmaceutical Stock
News for BMRN
News for BMRN
zacks.com
4 months ago
How to Buy BioMarin Pharmaceutical Inc Stock (BMRN)
1:13
How to Buy BioMarin Pharmaceutical Inc Stock (BMRN)
YouTubeInvesting Step by Step
3 views1 month ago
BMRN Stock (Biomarin Pharmaceutical stock analysis) BMRN STOCK PREDICTION BMRN STOCK analysis BMRN
1:09
BMRN Stock (Biomarin Pharmaceutical stock analysis) BMRN STOCK PREDICTION BMRN STOCK analysis BMRN
YouTubemr. sicko Trading
280 views8 months ago
At BioMarin, we're driven to develop innovative medicines that transform the lives of those with rare genetic conditions. Learn more about our commitment to clinical research and our active trials. | BioMarin Pharmaceutical Inc.
0:12
At BioMarin, we're driven to develop innovative medicines that transfor…
261.2K views2 months ago
FacebookBioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.: BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 ...
BioMarin Pharmaceutical Inc.: BioMarin Presents Five-Year Phas…
9 months ago
finanznachrichten.de
Biomarin Pharmaceutical Inc. Announces Positive Results of Phase 2 Proof-Of-Concept and Dose Finding Study of BMN 111
Biomarin Pharmaceutical Inc. Announces Positive Results of Ph…
Jun 17, 2015
marketscreener.com
Biomarin Newly Approved Drug for Rare, Childhood Disease Will Cost $700K Per Year
Biomarin Newly Approved Drug for Rare, Childhood Disease Will Cos…
Dec 7, 2019
thestreet.com
BioMarin Pharmaceutical Inc. Announces its Decision to Discontinue Development of BMN349
BioMarin Pharmaceutical Inc. Announces its Decision to Discon…
3 months ago
marketscreener.com
This Insider Has Just Sold Shares In BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
This Insider Has Just Sold Shares In BioMarin Pharmaceutical Inc. (NA…
Dec 5, 2021
nasdaq.com
BioMarin Pharmaceutical Inc.: BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
BioMarin Pharmaceutical Inc.: BioMarin Strengthens Enzyme Th…
11 months ago
finanznachrichten.de
BioMarin Pharmaceutical anticipe des charges IPR&D acquises d'en…
6 months ago
zonebourse.com
BioMarin Pharmaceutical Inc. : HC Wainwright révise son opinion et …
7 months ago
zonebourse.com
1:33
BioMarin Pharmaceutical CEO on the company's drug pricing strategy
Oct 19, 2022
CNBC
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for …
3 months ago
wsj.com
BioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money …
May 11, 2018
centralcharts.com
1:21
BioMarin CEO: System will determine the worth of new drug
Apr 28, 2017
CNBCJim Cramer
Should I Avoid BioMarin Pharmaceutical Inc. (BMRN)?
Sep 8, 2020
insidermonkey.com
1:06
The BioMarin 8: Operating Principles That Guide Our Work
745 viewsDec 19, 2024
YouTubeBioMarin
4:59
Living the BioMarin 8
2.7K viewsJan 30, 2025
YouTubeBioMarin
3:21
Biomarin Pharmaceutical
288 viewsJan 30, 2025
YouTubeWTVQ
1:58
Marine Biomedicine: production of food and biopharmaceuticals thro…
3.8K viewsMay 7, 2019
YouTubeScience Animated
0:16
#jpm25 | BioMarin Pharmaceutical Inc. | 12 comments
12 viewsJan 23, 2025
linkedin.com
5:51
BioMarin CEO: Biotech Breakthrough? | Mad Money | CNBC
2.4K viewsApr 21, 2016
YouTubeCNBC
1:06:29
Adolescence and PKU: Building a Path to Independence with BioMar…
89 views4 months ago
YouTubeNationalPKUAlliance
Products | BioMarin
Mar 25, 2024
biomarin.com
5:19
BioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money …
3.2K viewsMay 11, 2018
YouTubeCNBC
6:18
BioMarin is 'close as can get' to a hemophilia cure, CEO says
Oct 18, 2017
CNBCJim Cramer
0:38
BioMarin Pharmaceutical
83 views3 months ago
YouTubeThe Quiet Bull
8:57
BMRN Stock Could Double: Biomarin Pharmaceutical Stock A…
559 views8 months ago
YouTubeBusiness of Life - Investing
4:45
NO.5 国际生物医药初创公司——BioMarin Pharmaceutical
273 viewsMay 31, 2022
bilibili美股菜睇
2:25
Hemophilia AAV Gene Therapy Animation
3.3K viewsMay 10, 2024
YouTubeThe France Foundation
6:01
BioMarin Pharmaceutical CEO: Close to a Cure? | Mad Money | C…
1.3K viewsOct 19, 2017
YouTubeCNBC
See more videos
Static thumbnail place holder